According to a recent study, asthma increases the risk of complications during pregnancy and delivery as the patients suffer more often from preeclampsia (PE) and run a higher risk of giving birth to underweight babies.
These and other complications during pregnancy and delivery can not be explained by hereditary or environmental factors, says study.
Asthma is a common disease caused by chronic inflammation in the lungs with symptoms of coughing and breathlessness, and affects between 8-10 percent of women of childbearing age in Sweden.
Using data from the Swedish birth, prescribed drug and patient registers, researchers at Karolinska Institutet have been able to examine the link between asthma in pregnant women and pregnancy/delivery outcomes.
Studying more than one million births to just over 700,000 women between 2001 and 2013, they found that 10 percent of the babies born had a mother with asthma.
"Four percent of all pregnant women develop preeclampsia. We found that the risk of preeclampsia is 17 percent higher in women with asthma compared to women without asthma", says the study's lead author Dr Gustaf Rejno, obstetrician and doctoral student at Karolinska Institutet's Department of Medical Epidemiology and Biostatistics.
Additionally, women with asthma were more likely to have underweight babies, instrumental deliveries, caesarean sections and shorter pregnancies.
To ascertain whether the complications could be attributed to hereditary or environmental factors, the researchers also identified the women's asthma-free cousins and sisters who had given birth during the same period. On comparing the groups they found that the correlations between maternal asthma and complications during pregnancy and delivery held.
"It seems to be the asthma per se that causes these complications," says Dr Rejno. "This means that well-controlled asthma during pregnancy could reduce the relative incidence of complications during pregnancy and childbirth. In an earlier study we saw that this was indeed the case."
The study has been published in The Journal of Allergy and Clinical Immunology: In Practice.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
